Ying Lin Li

US Patent:

7424472, Sep 9, 2008

Filed:

May 27, 2005

Appl. No.:

11/138685

Inventors:

Chuang Wang - Beijing, CN
Joshua Forman - Somerville MA, US
Lee Wang - Kirkland WA, US
Xing Xie - Beijing, CN
Ying Li - Bellevue WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 7/00
G06F 17/30

US Classification:

707 4, 707 3, 715200

Abstract:

A system and method for location-specific searching. The invention correctly identifies explicit and implicit locations in a search query, and provides an appropriate dominant location. Top search results are obtained and analyzed to determine which terms in the query often appear in combination, and the query is tokenized based on the analysis. An explicit location indicating a location intent is most likely treated as an individual token, and the explicit location is treated as the dominant location of the query. In the case of a false positive, wherein the explicit location in a query is not the location intent, the explicit location is likely to be present with other terms that provide context. A token will likely include these terms together. The explicit location will therefore not be used to generate location-specific results in the case of a false positive.

US Patent:

8609632, Dec 17, 2013

Filed:

May 24, 2007

Appl. No.:

11/805829

Inventors:

Zachary Shriver - Cambridge MA, US
Mallikarjun Sundaram - Randolph NJ, US
Ganesh Venkataraman - Bedford MA, US
Pat Oliver-Shaffer - Acton MA, US
Yiming Yao - West Newton MA, US
Zainab Sirajbhai Mamuwala - Lowell MA, US
Ian David Fier - Southborough MA, US
Yiwei Qi - Andover MA, US
Ishan Capila - Ashland MA, US
Nur Sibel Gunay - Brookline MA, US
Daniela Beccati - Brighton MA, US
Cuihua Liu - Belmont MA, US
Corinne Bauer - Sudbury MA, US
Ying Li - Wellesley MA, US

Assignee:

Momenta Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A61K 31/727
A61K 31/715
A01N 43/04

US Classification:

514 56, 514 54

Abstract:

Preparations of low molecular weight heparins (LMWHs) having improved properties, e. g. , properties that provide a clinical advantage, are provided herein. Methods of making and using such preparations as well as methods of analyzing starting materials, processing, intermediates and final products in the production of such LMWH preparations are provided.

US Patent:

20100305022, Dec 2, 2010

Filed:

May 26, 2010

Appl. No.:

12/788264

Inventors:

Zachary Shriver - Cambridge MA, US
Mallikarjun Sundaram - Flemington NJ, US
Ganesh Venkataraman - Bedford MA, US
Pat Oliver-Shaffer - Acton MA, US
Yiming Yao - West Newton MA, US
Zainab Sirajbhai Mamuwala - Lowell MA, US
Ian David Fier - Southborough MA, US
Yiwei Qi - Andover MA, US
Ishan Capila - Ashland MA, US
Nur Sibel Gunay - Chestnut Hill MA, US
Daniela Beccati - Boston MA, US
Cuihua Liu - Belmont MA, US
Corinne Bauer - Sudbury MA, US
Ying Li - Wellesley MA, US

International Classification:

A61K 38/00
A61K 31/727
A61P 7/02
C12P 19/04

US Classification:

514 11, 514 56, 435101

Abstract:

Preparations of low molecular weight heparins (LMWHs) having improved properties, e.g., properties that provide a clinical advantage, are provided herein. Methods of making and using such preparations as well as methods of analyzing starting materials, processing, intermediates and final products in the production of such LMWH preparations are provided.

US Patent:

20140045740, Feb 13, 2014

Filed:

Aug 12, 2013

Appl. No.:

13/964862

Inventors:

Ying Li - Wellesley MA, US

Assignee:

Momenta Pharmaceuticals, Inc. - Cambridge MA

International Classification:

G01N 33/68
A61K 38/00

US Classification:

514 11, 530300, 436 86

Abstract:

The present disclosure relates to methods for assessing molecular weight characteristics of glatiramer acetate using SEC-MALS.

US Patent:

56057997, Feb 25, 1997

Filed:

Mar 28, 1995

Appl. No.:

8/411389

Inventors:

Raymond L. White - Salt Lake City UT
Richard M. Cawthon - Salt Lake City UT
Ying Li - Salt Lake City UT

Assignee:

University of Utah Research Foundation - Salt Lake City UT

International Classification:

C12Q 168
C12P 1934
C07H 2104
C12N 1500

US Classification:

435 6

Abstract:

The present invention is directed to somatic mutations of the NF1 gene which are found in human tumors. In addition, the present invention is directed to methods of screening humans to determine those having somatic mutations in the NF1 gene in tumors. Finally, the invention is directed to a method of treating a human having a tumor with a somatic mutation in the NF1 gene by restoring natural regulation of ras proteins.

US Patent:

20190130070, May 2, 2019

Filed:

Oct 31, 2017

Appl. No.:

15/799664

Inventors:

- Armonk NY, US
Soumya Ghosh - Boston MA, US
Jianying Hu - Bronx NY, US
Ying Li - Fort Lee NJ, US
Zhaonan Sun - Elmsford NY, US

International Classification:

G06F 19/00
G06Q 50/24

Abstract:

A system (or method) for generation and employment of disease progression model(s) that facilitates identifying and indexing discriminative features for disease progression in observational data. The disease progression prediction system comprises a processor that executes computer executable components stored in memory. A receiving component receives and learns observational patient data. A model generation component builds a preliminary disease progression model. An identification component identifies discriminative clinical features for different disease stages. A ranking component ranks discriminative powers of clinical features for respective pairs of disease stages; wherein the model generation component employs the ranked features to generate a final disease progression model.

US Patent:

20190034595, Jan 31, 2019

Filed:

Jul 27, 2017

Appl. No.:

15/661591

Inventors:

- Armonk NY, US
Soumya Ghosh - Boston MA, US
Ying Li - Fort Lee NJ, US
Yu Cheng - Ossining NY, US
Jianying Hu - Bronx NY, US

International Classification:

G06F 19/00

Abstract:

Embodiments describing an approach to receiving patient registry data and creating at least one control model based on the patient registry data. Transforming patient registry data into at least one prediction confident interval based on the at least one control model. Transforming the at least one prediction confident interval into at least one robust assessment score, and outputting the at least one robust assessment score for measuring disease progression indicators.

US Patent:

20180203180, Jul 19, 2018

Filed:

Jul 7, 2016

Appl. No.:

15/742656

Inventors:

- Lowell MA, US
Ying LI - Nashua NH, US

Assignee:

PERFORMANCE INDICATOR, LLC - Lowell MA

International Classification:

F21V 8/00
H05B 33/08

Abstract:

A lighting device includes a frame having an access panel. At least one LED is coupled to an interior edge of the frame and a light guide panel is positioned in the frame such that an edge is in communication with the LED. At least one light injection optic is coupled to the LED and the edge of the light guide panel, and is configured to direct light from the LED toward the edge of the light guide panel. At least one reflector is coupled to the LED, and is configured to direct light from the LED toward the edge of the light guide panel. At least one reflective sheet is coupled to a rear surface of the light guide panel and at least one color conversion sheet is coupled to a front surface of the light guide panel. A cover is coupled to the rear of the frame.